nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—PTGS2—bile duct cancer	0.773	1	CbGaD
Mesalazine—MPO—superior mesenteric artery—bile duct cancer	0.0828	0.686	CbGeAlD
Mesalazine—CHUK—liver—bile duct cancer	0.00399	0.0331	CbGeAlD
Mesalazine—ALOX5—pancreas—bile duct cancer	0.00353	0.0293	CbGeAlD
Mesalazine—CHUK—lymph node—bile duct cancer	0.00306	0.0254	CbGeAlD
Mesalazine—MPO—pancreas—bile duct cancer	0.00299	0.0248	CbGeAlD
Mesalazine—PTGS2—gall bladder—bile duct cancer	0.00294	0.0244	CbGeAlD
Mesalazine—IKBKB—liver—bile duct cancer	0.00271	0.0225	CbGeAlD
Mesalazine—PPARG—pancreas—bile duct cancer	0.00265	0.022	CbGeAlD
Mesalazine—ALOX5—liver—bile duct cancer	0.00225	0.0186	CbGeAlD
Mesalazine—IKBKB—lymph node—bile duct cancer	0.00208	0.0172	CbGeAlD
Mesalazine—MPO—liver—bile duct cancer	0.0019	0.0158	CbGeAlD
Mesalazine—Salicylate-sodium—PTGS2—bile duct cancer	0.00187	0.3	CrCbGaD
Mesalazine—ALOX5—lymph node—bile duct cancer	0.00172	0.0143	CbGeAlD
Mesalazine—PPARG—liver—bile duct cancer	0.00169	0.014	CbGeAlD
Mesalazine—MPO—lymph node—bile duct cancer	0.00146	0.0121	CbGeAlD
Mesalazine—PTGS2—pancreas—bile duct cancer	0.00136	0.0112	CbGeAlD
Mesalazine—PPARG—lymph node—bile duct cancer	0.00129	0.0107	CbGeAlD
Mesalazine—Olsalazine—PTGS2—bile duct cancer	0.00128	0.206	CrCbGaD
Mesalazine—Diflunisal—PTGS2—bile duct cancer	0.00121	0.193	CrCbGaD
Mesalazine—Aminosalicylic Acid—PTGS2—bile duct cancer	0.00121	0.193	CrCbGaD
Mesalazine—PTGS2—liver—bile duct cancer	0.000863	0.00715	CbGeAlD
Mesalazine—PTGS1—lymph node—bile duct cancer	0.000692	0.00574	CbGeAlD
Mesalazine—Salicylic acid—PTGS2—bile duct cancer	0.000671	0.108	CrCbGaD
Mesalazine—PTGS2—lymph node—bile duct cancer	0.000661	0.00548	CbGeAlD
Mesalazine—IKBKB—Signaling by Interleukins—HRAS—bile duct cancer	0.00014	0.0014	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—EGFR—bile duct cancer	0.00014	0.0014	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—NRAS—bile duct cancer	0.00014	0.0014	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—EGFR—bile duct cancer	0.000139	0.00139	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—NRAS—bile duct cancer	0.000139	0.00139	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	0.000139	0.00139	CbGpPWpGaD
Mesalazine—CHUK—Disease—IDH1—bile duct cancer	0.000139	0.00139	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—EGFR—bile duct cancer	0.000139	0.00139	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—KRAS—bile duct cancer	0.000138	0.00139	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—EGFR—bile duct cancer	0.000138	0.00138	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—IL6—bile duct cancer	0.000136	0.00136	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bile duct cancer	0.000136	0.00136	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—bile duct cancer	0.000135	0.00135	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—NRAS—bile duct cancer	0.000135	0.00135	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—bile duct cancer	0.000134	0.00134	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL6—bile duct cancer	0.000134	0.00134	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—KRAS—bile duct cancer	0.000132	0.00132	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—SLC5A5—bile duct cancer	0.000132	0.00132	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—KRAS—bile duct cancer	0.000132	0.00132	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—NRAS—bile duct cancer	0.000132	0.00132	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—KRAS—bile duct cancer	0.000132	0.00132	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—MMP9—bile duct cancer	0.000132	0.00132	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—KRAS—bile duct cancer	0.000131	0.00131	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—KRAS—bile duct cancer	0.00013	0.0013	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—IL6—bile duct cancer	0.00013	0.0013	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—bile duct cancer	0.00013	0.0013	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—EGFR—bile duct cancer	0.00013	0.0013	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—EGFR—bile duct cancer	0.00013	0.0013	CbGpPWpGaD
Mesalazine—IKBKB—Activated TLR4 signalling—IL6—bile duct cancer	0.000129	0.0013	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—bile duct cancer	0.000129	0.00129	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—EGFR—bile duct cancer	0.000129	0.00129	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KRAS—bile duct cancer	0.000128	0.00129	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—ERBB2—bile duct cancer	0.000127	0.00128	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—EGFR—bile duct cancer	0.000127	0.00128	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—EGFR—bile duct cancer	0.000127	0.00127	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—bile duct cancer	0.000126	0.00126	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TGFB1—bile duct cancer	0.000125	0.00125	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—HRAS—bile duct cancer	0.000125	0.00125	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000124	0.00125	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—IDH1—bile duct cancer	0.000124	0.00124	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000124	0.00124	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—bile duct cancer	0.000124	0.00124	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bile duct cancer	0.000123	0.00123	CbGpPWpGaD
Mesalazine—CHUK—BDNF signaling pathway—HRAS—bile duct cancer	0.000123	0.00123	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—EGFR—bile duct cancer	0.000123	0.00123	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—KRAS—bile duct cancer	0.000123	0.00123	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—KRAS—bile duct cancer	0.000123	0.00123	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—KRAS—bile duct cancer	0.000123	0.00123	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000122	0.00122	CbGpPWpGaD
Mesalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—bile duct cancer	0.000122	0.00122	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—KRAS—bile duct cancer	0.000121	0.00122	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—bile duct cancer	0.000121	0.00121	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—KRAS—bile duct cancer	0.00012	0.00121	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—EGFR—bile duct cancer	0.00012	0.0012	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MET—bile duct cancer	0.00012	0.0012	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—KRAS—bile duct cancer	0.00012	0.0012	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—IL6—bile duct cancer	0.00012	0.0012	CbGpPWpGaD
Mesalazine—CHUK—Toll-Like Receptors Cascades—IL6—bile duct cancer	0.00012	0.0012	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—HRAS—bile duct cancer	0.00012	0.0012	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—NRAS—bile duct cancer	0.000119	0.0012	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—HRAS—bile duct cancer	0.000118	0.00118	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—bile duct cancer	0.000118	0.00118	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—bile duct cancer	0.000116	0.00117	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—KRAS—bile duct cancer	0.000116	0.00116	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—ERBB2—bile duct cancer	0.000116	0.00116	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000115	0.00115	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—bile duct cancer	0.000115	0.00115	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—IL6—bile duct cancer	0.000114	0.00115	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—KRAS—bile duct cancer	0.000113	0.00114	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RNF43—bile duct cancer	0.000113	0.00113	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—IL6—bile duct cancer	0.000113	0.00113	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—HRAS—bile duct cancer	0.000112	0.00113	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—HRAS—bile duct cancer	0.000112	0.00112	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—HRAS—bile duct cancer	0.000112	0.00112	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—HRAS—bile duct cancer	0.000111	0.00112	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—HRAS—bile duct cancer	0.000111	0.00111	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—bile duct cancer	0.000111	0.00111	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—HRAS—bile duct cancer	0.000111	0.00111	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—bile duct cancer	0.00011	0.0011	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—bile duct cancer	0.000109	0.00109	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—EGFR—bile duct cancer	0.000109	0.00109	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—bile duct cancer	0.000109	0.00109	CbGpPWpGaD
Mesalazine—IKBKB—Toll-Like Receptors Cascades—IL6—bile duct cancer	0.000108	0.00109	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TGFB1—bile duct cancer	0.000108	0.00109	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—IL6—bile duct cancer	0.000108	0.00108	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—IL6—bile duct cancer	0.000107	0.00107	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—IL6—bile duct cancer	0.000106	0.00107	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—EGFR—bile duct cancer	0.000106	0.00106	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—IL6—bile duct cancer	0.000106	0.00106	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—bile duct cancer	0.000105	0.00105	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.000104	0.00104	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—HRAS—bile duct cancer	0.000104	0.00104	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—bile duct cancer	0.000104	0.00104	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—HRAS—bile duct cancer	0.000104	0.00104	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL6—bile duct cancer	0.000103	0.00103	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—HRAS—bile duct cancer	0.000103	0.00103	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—bile duct cancer	0.000103	0.00103	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—KRAS—bile duct cancer	0.000103	0.00103	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GNAS—bile duct cancer	0.000103	0.00103	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RNF43—bile duct cancer	0.000103	0.00103	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000102	0.00103	CbGpPWpGaD
Mesalazine—IKBKB—Insulin Signaling—HRAS—bile duct cancer	0.000102	0.00103	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—HRAS—bile duct cancer	0.000102	0.00102	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—HRAS—bile duct cancer	0.000102	0.00102	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—IDH2—bile duct cancer	0.000101	0.00101	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MMP2—bile duct cancer	0.0001	0.001	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—bile duct cancer	9.97e-05	0.000998	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—IL6—bile duct cancer	9.97e-05	0.000998	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—IL6—bile duct cancer	9.97e-05	0.000998	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—bile duct cancer	9.89e-05	0.000991	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—IL6—bile duct cancer	9.88e-05	0.000989	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—NRAS—bile duct cancer	9.87e-05	0.000988	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—IL6—bile duct cancer	9.79e-05	0.000981	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—IL6—bile duct cancer	9.75e-05	0.000976	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—NRAS—bile duct cancer	9.7e-05	0.000971	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—HRAS—bile duct cancer	9.64e-05	0.000965	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—IL6—bile duct cancer	9.59e-05	0.000961	CbGpPWpGaD
Mesalazine—PTGS2—Disease—RNF43—bile duct cancer	9.57e-05	0.000958	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—bile duct cancer	9.45e-05	0.000946	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	9.23e-05	0.000924	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—bile duct cancer	9.04e-05	0.000905	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—NRAS—bile duct cancer	8.95e-05	0.000896	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—bile duct cancer	8.92e-05	0.000894	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—EGFR—bile duct cancer	8.84e-05	0.000885	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	8.83e-05	0.000884	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—NRAS—bile duct cancer	8.79e-05	0.000881	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—ERBB2—bile duct cancer	8.77e-05	0.000878	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—HRAS—bile duct cancer	8.74e-05	0.000875	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—IDH1—bile duct cancer	8.68e-05	0.000869	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—KRAS—bile duct cancer	8.49e-05	0.00085	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—KRAS—bile duct cancer	8.35e-05	0.000836	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IDH1—bile duct cancer	8.23e-05	0.000824	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—SLC5A5—bile duct cancer	8.17e-05	0.000819	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL6—bile duct cancer	8.17e-05	0.000818	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—SMAD4—bile duct cancer	8.01e-05	0.000803	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—EGFR—bile duct cancer	8.01e-05	0.000802	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—IDH2—bile duct cancer	8.01e-05	0.000802	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—KRAS—bile duct cancer	7.7e-05	0.000771	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	7.66e-05	0.000767	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—KRAS—bile duct cancer	7.57e-05	0.000758	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MMP9—bile duct cancer	7.52e-05	0.000753	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFBR2—bile duct cancer	7.38e-05	0.000739	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	7.37e-05	0.000738	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HGF—bile duct cancer	7.35e-05	0.000736	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—ERBB2—bile duct cancer	7.27e-05	0.000728	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	7.23e-05	0.000724	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—HRAS—bile duct cancer	7.22e-05	0.000723	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—HRAS—bile duct cancer	7.1e-05	0.000711	CbGpPWpGaD
Mesalazine—CHUK—Disease—SMAD4—bile duct cancer	6.99e-05	0.0007	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—ERBB2—bile duct cancer	6.98e-05	0.000699	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—bile duct cancer	6.91e-05	0.000692	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—IDH1—bile duct cancer	6.89e-05	0.00069	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	6.83e-05	0.000684	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—bile duct cancer	6.79e-05	0.00068	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—NRAS—bile duct cancer	6.67e-05	0.000668	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HGF—bile duct cancer	6.66e-05	0.000667	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—ERBB2—bile duct cancer	6.59e-05	0.00066	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—HRAS—bile duct cancer	6.54e-05	0.000655	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—HRAS—bile duct cancer	6.43e-05	0.000644	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GNAS—bile duct cancer	6.35e-05	0.000636	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—ERBB2—bile duct cancer	6.33e-05	0.000634	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—bile duct cancer	6.26e-05	0.000627	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TGFB1—bile duct cancer	6.2e-05	0.000621	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—bile duct cancer	6.16e-05	0.000617	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—EGFR—bile duct cancer	6.08e-05	0.000609	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	6.07e-05	0.000608	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—KRAS—bile duct cancer	5.74e-05	0.000575	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—SLC5A5—bile duct cancer	5.73e-05	0.000573	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—NRAS—bile duct cancer	5.53e-05	0.000554	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTGS2—bile duct cancer	5.51e-05	0.000552	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	5.37e-05	0.000537	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—NRAS—bile duct cancer	5.31e-05	0.000532	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS2—bile duct cancer	5.2e-05	0.000521	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFBR2—bile duct cancer	5.17e-05	0.000518	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—EGFR—bile duct cancer	5.04e-05	0.000505	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—NRAS—bile duct cancer	5.02e-05	0.000502	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GNAS—bile duct cancer	4.99e-05	0.000499	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SMAD4—bile duct cancer	4.89e-05	0.00049	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—HRAS—bile duct cancer	4.88e-05	0.000489	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—EGFR—bile duct cancer	4.84e-05	0.000485	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—NRAS—bile duct cancer	4.82e-05	0.000482	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—KRAS—bile duct cancer	4.76e-05	0.000477	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFBR2—bile duct cancer	4.69e-05	0.000469	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—bile duct cancer	4.67e-05	0.000468	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—KRAS—bile duct cancer	4.57e-05	0.000458	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—EGFR—bile duct cancer	4.57e-05	0.000458	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—SLC5A5—bile duct cancer	4.55e-05	0.000455	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GNAS—bile duct cancer	4.52e-05	0.000453	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GNAS—bile duct cancer	4.45e-05	0.000446	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SMAD4—bile duct cancer	4.44e-05	0.000444	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—EGFR—bile duct cancer	4.39e-05	0.00044	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFBR2—bile duct cancer	4.37e-05	0.000438	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—KRAS—bile duct cancer	4.32e-05	0.000432	CbGpPWpGaD
Mesalazine—CHUK—Immune System—ERBB2—bile duct cancer	4.24e-05	0.000424	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—KRAS—bile duct cancer	4.15e-05	0.000415	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SMAD4—bile duct cancer	4.14e-05	0.000414	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—HRAS—bile duct cancer	4.05e-05	0.000405	CbGpPWpGaD
Mesalazine—CHUK—Disease—ERBB2—bile duct cancer	3.91e-05	0.000392	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HRAS—bile duct cancer	3.89e-05	0.000389	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—bile duct cancer	3.87e-05	0.000388	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ERBB2—bile duct cancer	3.84e-05	0.000385	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTGS2—bile duct cancer	3.82e-05	0.000383	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—HRAS—bile duct cancer	3.67e-05	0.000368	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GNAS—bile duct cancer	3.53e-05	0.000354	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HRAS—bile duct cancer	3.52e-05	0.000353	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—bile duct cancer	3.51e-05	0.000352	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS2—bile duct cancer	3.41e-05	0.000342	CbGpPWpGaD
Mesalazine—CHUK—Immune System—NRAS—bile duct cancer	3.22e-05	0.000323	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS2—bile duct cancer	3.08e-05	0.000308	CbGpPWpGaD
Mesalazine—CHUK—Disease—NRAS—bile duct cancer	2.97e-05	0.000298	CbGpPWpGaD
Mesalazine—CHUK—Immune System—EGFR—bile duct cancer	2.94e-05	0.000294	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—NRAS—bile duct cancer	2.92e-05	0.000293	CbGpPWpGaD
Mesalazine—CHUK—Immune System—KRAS—bile duct cancer	2.77e-05	0.000278	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFB1—bile duct cancer	2.76e-05	0.000277	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ERBB2—bile duct cancer	2.74e-05	0.000274	CbGpPWpGaD
Mesalazine—CHUK—Disease—EGFR—bile duct cancer	2.71e-05	0.000271	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—EGFR—bile duct cancer	2.66e-05	0.000267	CbGpPWpGaD
Mesalazine—CHUK—Disease—KRAS—bile duct cancer	2.56e-05	0.000256	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—KRAS—bile duct cancer	2.51e-05	0.000252	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ERBB2—bile duct cancer	2.48e-05	0.000249	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGS2—bile duct cancer	2.39e-05	0.000239	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HRAS—bile duct cancer	2.36e-05	0.000236	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MMP9—bile duct cancer	2.35e-05	0.000235	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ERBB2—bile duct cancer	2.32e-05	0.000232	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—bile duct cancer	2.26e-05	0.000226	CbGpPWpGaD
Mesalazine—CHUK—Disease—HRAS—bile duct cancer	2.18e-05	0.000218	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HRAS—bile duct cancer	2.14e-05	0.000214	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MMP9—bile duct cancer	2.13e-05	0.000213	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NRAS—bile duct cancer	2.08e-05	0.000209	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—bile duct cancer	2.08e-05	0.000209	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—bile duct cancer	2.05e-05	0.000205	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFB1—bile duct cancer	1.94e-05	0.000194	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EGFR—bile duct cancer	1.9e-05	0.00019	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NRAS—bile duct cancer	1.89e-05	0.000189	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—KRAS—bile duct cancer	1.79e-05	0.00018	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NRAS—bile duct cancer	1.76e-05	0.000176	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFB1—bile duct cancer	1.76e-05	0.000176	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EGFR—bile duct cancer	1.72e-05	0.000172	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFB1—bile duct cancer	1.64e-05	0.000164	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—KRAS—bile duct cancer	1.63e-05	0.000163	CbGpPWpGaD
Mesalazine—PTGS2—Disease—EGFR—bile duct cancer	1.61e-05	0.000161	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—bile duct cancer	1.59e-05	0.00016	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HRAS—bile duct cancer	1.52e-05	0.000153	CbGpPWpGaD
Mesalazine—PTGS2—Disease—KRAS—bile duct cancer	1.52e-05	0.000152	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—bile duct cancer	1.46e-05	0.000146	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—bile duct cancer	1.45e-05	0.000145	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HRAS—bile duct cancer	1.38e-05	0.000138	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—bile duct cancer	1.32e-05	0.000132	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HRAS—bile duct cancer	1.29e-05	0.000129	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—bile duct cancer	1.23e-05	0.000124	CbGpPWpGaD
